High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Explore this paper's citation graph
Summary
A consistent inverse relation of high-density lipoprotein cholesterol levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.
- Type
- article
- Published
- 1989-01-01
- Cited by
- 3,232
- References
- 35
- Access
- Open access
- OpenAlex
- https://openalex.org/W2077760013
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:819018
Keywords
Medicine, Framingham Heart Study, Internal medicine, Framingham Risk Score, Body mass index
References
- High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.
- A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.
- High density lipoprotein metabolism.
- Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death.
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
- Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial.
- High density lipoprotein is not a major risk factor for ischaemic heart disease in British men
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
- Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.
- A comparison of the logistic risk function and the proportional hazards model in prospective epidemiologic studies.
- Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study.
- Epidemiological approaches to heart disease: the Framingham Study.
- High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
- High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
- Predictive value of the exercise tolerance test for mortality in North American men: the Lipid Research Clinics Mortality Follow-up Study.
- Contractile Performance of the Hypertrophied Ventricle in Patients with Systemic Hypertension
- Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
- HDL serum cholesterol and 24-year mortality of men in Finland.
- The Lipid Research Clinics Program Prevalence Study.
- High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.
Cited by
- HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men
- Dyslipidemia and atypical antipsychotic drugs.
- Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism.
- Kinetics of lipids, apolipoproteins, and cholesteryl ester transfer protein in plasma after a bicycle marathon.
- Sex steroids, psychosocial factors, and lipid metabolism.
- Diabetes Mellitus and Coronary Artery Disease
- Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels.
- African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study.
- Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter.
- Physical Activity and High Density Lipoprotein Cholesterol Levels
- Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism.
- Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
- Old and new cardiovascular risk factors: from unresolved issues to new opportunities.
- Comparison of three homogeneous methods for measuring high-density lipoprotein cholesterol with a precipitation method in diabetic and non-diabetic subjects
- Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks.
- Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease.
- 4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent.
- Antidyslipidemic activity of furano-flavonoids isolated from Indigofera tinctoria.
- Expanding options with a wider range of rosuvastatin doses.
- Coronary Artery Diseases in South Asian Immigrants: An Update on High Density Lipoprotein Role in Disease Prevention
Related papers
- Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients
- State of the art coronary heart disease risk estimations based on the Framingham heart study.
- Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)
- Serum Uric Acid and Cardiovascular Disease Risk
- Research on the statistical analysis methods of heart disease: taking the Framingham Heart Study as an example
- Abstract 10666: Epigenetic Risk Score Capturing Alcohol Consumption is Not Associated with Cardiac Structure and Function: The Framingham Heart Study
- Contributions of the Framingham Heart Study to the Epidemiology of Coronary Heart Disease
- Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?
- Blood Pressure as a Risk Factor for Cardiovascular Disease The Framingham Study—30 Years of Follow‐up